H.I.G.-BAYSIDE-CAPITAL
H.I.G. Bayside Capital (“Bayside”), the special situations and distressed debt affiliate of H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with $52 billion of equity capital under management, is pleased to announce that its Bayside European Loan Opportunity Fund V was named “Best Performing Debt Fund Over $1.5B” by Private Equity Wire/Bloomberg.
Co-Heads of Bayside Europe’s special situations debt activities, Duncan Priston and Andrew Scotland, commented, “We are delighted to receive this award on behalf of the European Bayside team in recognition of our market leading and consistent performance. We look forward to continuing to work with our partners to deliver outstanding returns to our investors.”
About Bayside Capital
Bayside Capital is the special situations affiliate of H.I.G. Capital. Focused on middle market companies, Bayside invests across several segments of the primary and secondary debt capital markets with an emphasis on long term returns. With eight offices throughout the U.S. and Europe and over 500 investment professionals to draw upon, Bayside has the experience, resources, and flexibility required to generate superior risk-adjusted returns. For more information, please refer to the Bayside website at www.bayside.com.
About H.I.G. Capital
H.I.G. is a leading global alternative assets investment firm with $52 billion of equity capital under management.* Based in Miami, and with offices in New York, Boston, Chicago, Dallas, Los Angeles, San Francisco, and Atlanta in the U.S., as well as international affiliate offices in London, Hamburg, Madrid, Milan, Paris, Rio de Janeiro, São Paulo and Bogotá, H.I.G. specializes in providing both debt and equity capital to small and mid-sized companies, utilizing a flexible and operationally focused/value-added approach:
- H.I.G.’s equity funds invest in management buyouts, recapitalizations and corporate carve-outs of both profitable as well as underperforming manufacturing and service businesses.
- H.I.G.’s debt funds invest in senior, unitranche and junior debt financing to companies across the size spectrum, both on a primary (direct origination) basis, as well as in the secondary markets. H.I.G. is also a leading CLO manager, through its WhiteHorse family of vehicles, and manages a publicly traded BDC, WhiteHorse Finance.
- H.I.G.’s real estate funds invest in value-added properties, which can benefit from improved asset management practices.
- H.I.G. Infrastructure focuses on making value-add and core plus investments in the infrastructure sector.
Since its founding in 1993, H.I.G. has invested in and managed more than 300 companies worldwide. The firm's current portfolio includes more than 100 companies with combined sales in excess of $30 billion. For more information, please refer to the H.I.G. website at www.higcapital.com.
* Based on total capital commitments managed by H.I.G. Capital and affiliates.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221115006363/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Crown Bioscience Achieves Second CLIA Certification of 2025 at Suzhou Laboratory30.10.2025 13:30:00 CET | Press release
Crown Bioscience, a global contract research organization (CRO) headquartered in the United States and part of JSR Life Sciences and Japan-based JSR Corporation, today announced that its Suzhou, China laboratory has received Clinical Laboratory Improvement Amendments (CLIA) certification. This achievement marks the company’s second CLIA certification in 2025, following its San Diego facility earlier this year, underscoring Crown Bioscience’s continued commitment to expanding its global network of compliant, clinical-grade laboratories. Regulated by the Centers for Medicare and Medicaid Services (CMS), CLIA certification sets the highest federal standards for laboratory accuracy, reliability, and quality. The designation affirms that Crown Bioscience’s Suzhou laboratory meets all required compliance benchmarks, providing clients with greater confidence in the biomarker data that supports their clinical development and regulatory submissions. ‘’Earning a second CLIA certification within
SLB OneSubsea Secures EPC Contracts from PTTEP for Two Deepwater Projects Offshore Malaysia30.10.2025 13:30:00 CET | Press release
Integrated subsea production systems will help unlock important oil and gas reserves Global energy technology company SLB (NYSE: SLB) announced today the award of two sizeable engineering, procurement, and construction (EPC) contracts by PTT Exploration and Production Public Company Limited (PTTEP) to its OneSubsea™ joint venture. The contracts build on a 20-year collaboration between the two companies and cover the expansion of two fields offshore Malaysia. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251030090404/en/ As part of the EPC contracts, SLB OneSubsea will deliver comprehensive subsea production systems (SPS) for the Alum, Bemban, and Permai deepwater gas fields located in Block H and the Kikeh field, Malaysia’s first deepwater oil project. As part of the EPC contracts, SLB OneSubsea will deliver comprehensive subsea production systems (SPS) for the Alum, Bemban, and Permai deepwater gas fields located in Block
2025 Ecolab Watermark™Study Reveals Hidden Impact of Artificial Intelligence30.10.2025 13:30:00 CET | Press release
New findings connect rapid AI growth to new business opportunities and global water security Ecolab, a global sustainability leader offering water solutions and services, today announced findings from its third annual Ecolab Watermark™ Study, which reports on water stewardship around the world. This year’s research highlights water’s connection to timely global trends, including new business opportunities from the rapid growth of artificial intelligence (AI) and consumer concern about its impact on vital natural resources. According to the Watermark Study, a majority of consumers across fifteen countries understand the power demands of AI, but far fewer recognize the hidden impact of AI – the amount of water required to manufacture AI technology and operate data centers. In the United States (U.S.), just 46% of consumers acknowledge the use of water in AI operations compared to 55% recognizing the use of power. In other regions, including Asia Pacific and Latin America, the gap is even
Novotech Maps Global Growth in Radiopharmaceutical Trials30.10.2025 13:05:00 CET | Press release
Novotech, a leading global clinical research organization (CRO) and scientific advisory partner, today released a new white paper detailing the rapid rise of therapeutic radiopharmaceutical research and the operational frameworks needed to support these complex studies at scale. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251030722919/en/ The analysis shows that global therapeutic radiopharmaceutical trials have grown from just a handful in 2018 to more than 80 active studies by August 2025, a tenfold increase highlighting the growth in this advancing area of precision oncology. Therapeutic radiopharmaceuticals deliver targeted radiation directly to tumors via beta and alpha emitters, minimizing off-target exposure. The white paper highlights the clinical role of beta emitters such as Lutetium-177, the growing interest in targeted alpha therapy (TAT), and the critical supply-chain challenges posed by short-lived isotopes
AT&T and Thales Collaborate to Revolutionize IoT Deployments With New eSIM Solution30.10.2025 13:00:00 CET | Press release
AT&T and Thales introduce a next generation eSIM solution, powered by the latest GSMA IoT specification (SGP.32), giving enterprises a consolidated platform to remotely and securely manage IoT subscriptions, while preserving device integrity on a highly secure and reliable network.Backed by Thales’ “secure by design” approach, this solution targets the highest level of cybersecurity for IoT devices and supports compliance with evolving global cybersecurity regulations.Optimized for large-scale IoT deployments, the new eSIM management platform simplifies operations, reduces costs, and delivers advanced automation beyond SGP.32 standards to support diverse industries and device types. With over 5.8 billion IoT cellular connections expected globally by 2030 (GSMA Intelligence) — powering everything from smart meters to wearable health trackers — the need for secure, scalable, and easy-to-manage connectivity is greater than ever. AT&T, a leader in connectivity and IoT solutions, and Thales
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
